June 1 – June 9, 2013
In this section, we will highlight the some of the high-impact studies, updates, and analyses published in medicine during the past week.
Controlled Trial of Psychotherapy for Congolese Survivors of Sexual Violence
In this cluster randomized control trial from the Democratic Republic of Congo, women subject...
1. Treatment with the anti-C5 monoclonal antibody eculizumab significantly improved hematologic markers and GFR in patients with atypical hemolytic uremic syndrome.
2. The improvements in hematologic markers and GFR were sustained beyond the duration of therapy.
Evidence Rating Level: 2 (Good)
Study Rundown: Atypical hemolytic-uremic syndrome (AHUS) is a genetic disease...